Update |
April 16, 2026
Pharmacogenomic testing for DPYD polymorphisms with fluoropyrimidine therapies – Available at North Thames GMS
We are one of seven regional services established by the NHS Genomic Medicine Service, each responsible for coordinating genomics for part of England. Through the work of the GMS, the NHS will become the first health service in the world to embed genomics into routine care. We are working to provide equitable access to genomic testing and innovation for people across North London, Hertfordshire and Mid and South Essex.
Read more About GMS
Update |
April 16, 2026
Pharmacogenomic testing for DPYD polymorphisms with fluoropyrimidine therapies – Available at North Thames GMS
Update |
April 14, 2026
Summary of changes to eligibility criteria in the National Genomics Test Directory – Rare & Inherited Disease
Update |
March 5, 2026
ctDNA Guidance for Clinicians for Patients with Advanced Lung Cancer